Beyond lipid lowering, curcumin has been associated with reductions in liver enzymes in NAFLD, improvements in glycemic indices in T2DM, and decreases in inflammatory biomarkers such as CRP and IL-6. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.